check_circleStudy Completed

Biological Availability, Postmenopause, Hormone Replacement Therapy

Study to compare the bioavailability of estriol after single oral administration of the two estriol-containing preparations in postmenopausal women

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
24
Trial Dates
January 2003 - February 2003
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Estriol (E3)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Open-label, randomized, two-way crossover study to compare the bioavailability of estriol after single oral administration of the two estriolcontaining preparations Estriol 2 mg JENAPHARM® and a microcrystalline estriol suspension in 24 healthy postmenopausal volunteers
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A